These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32571620)

  • 41. Ketoacidosis as a side-effect of clozapine: a case report.
    Kostakoğlu AE; Yazici KM; Erbaş T; Güvener N
    Acta Psychiatr Scand; 1996 Mar; 93(3):217-8. PubMed ID: 8739670
    [No Abstract]   [Full Text] [Related]  

  • 42. Eosinophilia and parotitis occurring early in clozapine treatment.
    Saguem BN; Bouhlel S; Ben Salem C; Ben Hadj Ali B
    Int J Clin Pharm; 2015 Dec; 37(6):992-5. PubMed ID: 26373547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful rechallenge with clozapine after eosinophilia.
    Roberts CE; Mortenson LY; Merrill DB; Rafizadeh N; Smith TE; Lieberman JA
    Am J Psychiatry; 2011 Nov; 168(11):1147-51. PubMed ID: 22193601
    [No Abstract]   [Full Text] [Related]  

  • 44. Optimizing outcomes in clozapine rechallenge following neutropenia using human leukocyte antigen typing: A case report.
    Yamaki N; Hishimoto A; Otsuka I; Sasada T; Boku S; Saito T; Yasuda Y; Yamamori H; Ikeda M; Ikeda M; Sora I; Iwata N; Hashimoto R
    Psychiatry Clin Neurosci; 2017 Apr; 71(4):289-290. PubMed ID: 28097743
    [No Abstract]   [Full Text] [Related]  

  • 45. Clozapine-associated asterixis: case report.
    Kwak YT; Yang Y; Koo MS
    J Clin Psychopharmacol; 2014 Feb; 34(1):165-7. PubMed ID: 24158019
    [No Abstract]   [Full Text] [Related]  

  • 46. Successful re-challenge with clozapine following development of clozapine-induced cardiomyopathy.
    Floreani J; Bastiampillai T
    Aust N Z J Psychiatry; 2008 Aug; 42(8):747-8. PubMed ID: 18642408
    [No Abstract]   [Full Text] [Related]  

  • 47. Clozapine induced akathisia: a case report and review of the evidence.
    Grover S; Sahoo S
    Indian J Pharmacol; 2015; 47(2):234-5. PubMed ID: 25878393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistant-schizophrenia after discontinuation of clozapine: report of two cases.
    Lamia D; Olfa BA; Ines J; Karim T
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1553-4. PubMed ID: 19665510
    [No Abstract]   [Full Text] [Related]  

  • 49. Clozapine-induced esophagitis at therapeutic dose: a case report.
    Gonçalves B; Castro J; Zanini MA; Bittencourt L; Gadelha A; Cunha GR; Coelho FM; Tufik S; Bressan RA; Brietzke E
    Braz J Psychiatry; 2016; 38(2):176-177. PubMed ID: 27304761
    [No Abstract]   [Full Text] [Related]  

  • 50. Clozapine induced polyserositis.
    Catalano G; Catalano MC; Frankel Wetter RL
    Clin Neuropharmacol; 1997 Aug; 20(4):352-6. PubMed ID: 9260733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulmonary Embolism and Clozapine Use: A Case Report and Literature Review.
    Gami RK; Mishra P; Sedlak T
    Psychosomatics; 2017; 58(2):203-208. PubMed ID: 28104337
    [No Abstract]   [Full Text] [Related]  

  • 52. A case of clozapine-induced paralytic ileus.
    Rondla S; Crane S
    Emerg Med J; 2007 Feb; 24(2):e12. PubMed ID: 17251601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis.
    Rudolf J; Grond M; Neveling M; Heiss WD
    J Neural Transm (Vienna); 1997; 104(11-12):1305-11. PubMed ID: 9503276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study.
    Hung GC; Liu HC; Yang SY; Pan CH; Liao YT; Chen CC; Kuo CJ
    J Clin Psychiatry; 2016 Jan; 77(1):60-6. PubMed ID: 26613551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Three case reports of emergent dyskinesia with clozapine.
    Gafoor R; Brophy J
    Eur Psychiatry; 2003 Aug; 18(5):260-1. PubMed ID: 12927329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pericardial effusion in patients with schizophrenia: are they on clozapine?
    Raju P; Rao GK; Davis G
    Emerg Med J; 2008 Jun; 25(6):383-4. PubMed ID: 18499836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Routine data linkage to identify and monitor diabetes in clozapine-treated patients with schizophrenia.
    Pearsall R; Gareze J; Park J; Walker A; Langan-Martin J; McLean G; Connelly M; Mackay D; Smith DJ
    Schizophr Res; 2016 Dec; 178(1-3):107-108. PubMed ID: 27614569
    [No Abstract]   [Full Text] [Related]  

  • 58. Reversible myocarditis in a patient receiving clozapine.
    Kirpekar VC; Deshpande SM; Joshi PP
    Indian Heart J; 2001; 53(6):779-81. PubMed ID: 11838936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: a case report.
    De Berardis D; Campanella D; Serroni N; Rapini G; Olivieri L; Fornaro M; Valchera A; Iasevoli F; Napoletano C; Martinotti G; Giannantonio MD
    J Clin Psychopharmacol; 2014 Oct; 34(5):649-51. PubMed ID: 25006818
    [No Abstract]   [Full Text] [Related]  

  • 60. Successful electroconvulsive therapy and improvement of negative symptoms in refractory schizophrenia with clozapine-induced seizures: a case report.
    Park S; Lee MK
    Psychiatr Danub; 2014 Dec; 26(4):360-2. PubMed ID: 25377372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.